Similar articles

• Introduction to "Molecular drivers of prostate cancer development, progression, and resistance to therapy".

  Barbieri CE. Barbieri CE. Urol Oncol. 2018 Aug;36(8):367. doi: 10.1016/j.urolonc.2018.06.003. Epub 2018 Jul 29. Urol Oncol. 2018. PMID: 30064932 Review. No abstract available.
• Genomics, transcriptomics and proteomics: enabling insights into social evolution and disease challenges for managed and wild bees.

  Trapp J, McAfee A, Foster LJ. Trapp J, et al. Mol Ecol. 2017 Feb;26(3):718-739. doi: 10.1111/mec.13986. Epub 2017 Feb 1. Mol Ecol. 2017. PMID: 28026896 Review.
• Noncontact laser catapulting: a basic procedure for functional genomics and proteomics.

  Westphal G, Burgemeister R, Friedemann G, Wellmann A, Wernert N, Wollscheid V, Becker B, Vogt T, Knüchel R, Stolz W, Schütze K. Westphal G, et al. Methods Enzymol. 2002;356:80-99. doi: 10.1016/s0076-6879(02)56925-1. Methods Enzymol. 2002. PMID: 12418190 No abstract available.
• Genomics of prostate cancer: is there anything to "translate"?

  Kopper L, Tímár J. Kopper L, et al. Pathol Oncol Res. 2005;11(4):197-203. doi: 10.1007/BF02893851. Epub 2005 Dec 31. Pathol Oncol Res. 2005. PMID: 16388315 Review.
• Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression.

  Latonen L, Afyounian E, Jylhä A, Nättinen J, Aapola U, Annala M, Kivinummi KK, Tammela TTL, Beuerman RW, Uusitalo H, Nykter M, Visakorpi T. Latonen L, et al. Nat Commun. 2018 Mar 21;9(1):1176. doi: 10.1038/s41467-018-03573-6. Nat Commun. 2018. PMID: 29563510 Free PMC article.